Mbele S, Vasaikar S
S Afr Fam Pract (2004). 2025; 67(1):e1-e10.
PMID: 39935157
PMC: 11886460.
DOI: 10.4102/safp.v67i1.6029.
Kim M, Jeon K, Kym D, Jung J, Jang Y, Han S
Antimicrob Resist Infect Control. 2025; 14(1):3.
PMID: 39881424
PMC: 11780852.
DOI: 10.1186/s13756-025-01514-9.
Guo X, Wu D, Chen X, Lin J, Chen J, Wang L
Infect Drug Resist. 2024; 17:4717-4726.
PMID: 39494229
PMC: 11529608.
DOI: 10.2147/IDR.S485915.
Stemler J, Gavriilaki E, Hlukhareva O, Khanna N, Neofytos D, Akova M
Ther Adv Infect Dis. 2024; 11:20499361241271863.
PMID: 39493728
PMC: 11528667.
DOI: 10.1177/20499361241271863.
Fanelli C, Pistidda L, Terragni P, Pasero D
Antibiotics (Basel). 2024; 13(8).
PMID: 39200090
PMC: 11351734.
DOI: 10.3390/antibiotics13080789.
Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units.
Kuloglu T, Unuvar G, Cevahir F, Kilic A, Alp E
J Intensive Med. 2024; 4(3):347-354.
PMID: 39035617
PMC: 11258511.
DOI: 10.1016/j.jointm.2023.11.007.
Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
Hassoun-Kheir N, Hussien K, Karram M, Saffuri M, Badaan S, Peleg S
Antimicrob Resist Infect Control. 2023; 12(1):129.
PMID: 37986092
PMC: 10658805.
DOI: 10.1186/s13756-023-01323-y.
Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis.
Tesfa T, Mitiku H, Edae M, Assefa N
Syst Rev. 2022; 11(1):240.
PMID: 36380387
PMC: 9667607.
DOI: 10.1186/s13643-022-02110-3.
Active Surveillance Cultures and Procalcitonin in Combination With Clinical Data to Guide Empirical Antimicrobial Therapy in Hospitalized Medical Patients With Sepsis.
Spoto S, Markley J, Valeriani E, Abbate A, Argemi J, Markley R
Front Microbiol. 2022; 13:797932.
PMID: 35464939
PMC: 9023116.
DOI: 10.3389/fmicb.2022.797932.
A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.
Calayan C, Barnes S, Pineles L, Harris A, Klein E
Front Public Health. 2022; 10:853757.
PMID: 35372195
PMC: 8968755.
DOI: 10.3389/fpubh.2022.853757.
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.
Jean S, Harnod D, Hsueh P
Front Cell Infect Microbiol. 2022; 12:823684.
PMID: 35372099
PMC: 8965008.
DOI: 10.3389/fcimb.2022.823684.
Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients.
Cano A, Gutierrez-Gutierrez B, Machuca I, Torre-Gimenez J, Gracia-Ahufinger I, Natera A
Microbiol Spectr. 2022; 10(2):e0197021.
PMID: 35323035
PMC: 9045231.
DOI: 10.1128/spectrum.01970-21.
Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies.
Changruenngam S, Modchang C, Bicout D
Sci Rep. 2022; 12(1):3805.
PMID: 35264643
PMC: 8907197.
DOI: 10.1038/s41598-022-07728-w.
Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units.
Yi J, Kim K
Acute Crit Care. 2021; 36(3):175-184.
PMID: 34380190
PMC: 8435449.
DOI: 10.4266/acc.2021.00409.
Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.
Chen H, Jean S, Lee Y, Lu M, Ko W, Liu P
Front Cell Infect Microbiol. 2021; 11:601968.
PMID: 33968793
PMC: 8102866.
DOI: 10.3389/fcimb.2021.601968.
A Polyclonal Spread Emerged: Characteristics of Carbapenem-Resistant Isolates from the Intensive Care Unit in a Chinese Tertiary Hospital.
Wang Z, Yu F, Shen X, Li M
Pol J Microbiol. 2021; 69(3):311-319.
PMID: 33574860
PMC: 7810120.
DOI: 10.33073/pjm-2020-034.
Risk Factors for Subsequential Carbapenem-Resistant Clinical Infection Among Rectal Carriers with Carbapenem-Resistant .
Chen X, Liu Q, Liu W, Yan Q
Infect Drug Resist. 2020; 13:1299-1305.
PMID: 32440167
PMC: 7211322.
DOI: 10.2147/IDR.S247101.
Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae.
Rivera-Espinar F, Machuca I, Tejero R, Rodriguez J, Mula A, Marfil E
Antimicrob Agents Chemother. 2020; 64(6).
PMID: 32205347
PMC: 7269473.
DOI: 10.1128/AAC.02164-19.
Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.
Mathers A, Vegesana K, German-Mesner I, Ainsworth J, Pannone A, Crook D
J Hosp Infect. 2020; 104(4):456-468.
PMID: 31931046
PMC: 7193892.
DOI: 10.1016/j.jhin.2020.01.005.
Prevalence and Risk Factors of Carbapenem-resistant Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study.
Kang J, Yi J, Ko M, Lee S, Lee J, Kim K
J Korean Med Sci. 2019; 34(18):e140.
PMID: 31074254
PMC: 6509365.
DOI: 10.3346/jkms.2019.34.e140.